INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 49m ago
HOUSE PTR8m ago
SEC 13F8m ago
ROBINHOOD CHAIN8m ago
Corporate insider
HA

Hasija Amit

CFO & EVP of Corp. DevelopmentCIK 0001787700

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 2
Max Insider Score62
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
HA
Hasija AmitCFO & EVP of Corp. Development
MISTMilestone Pharmaceuticals Inc.
Option exercise
M—
20.1K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Milestone Pharmaceuticals Inc.CFO & EVP of Corp. Development · Jan 28, 2026
62
HA
Hasija AmitCFO & EVP of Corp. Development
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL
$135K
58.0K sh
Dec 15, 2025
Jan 28, 2026
traded Dec 15, 2025
+44d
SEC FORM 4

Evidence

13
HA
Hasija AmitCFO & EVP of Corp. Development
MISTMilestone Pharmaceuticals Inc.
Option exercise
M—
20.1K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC FORM 4

Evidence

24
HA
Hasija AmitCFO & EVP of Corp. Development
MISTMilestone Pharmaceuticals Inc.
Grant or award
A—
100.0K sh
Dec 12, 2025Jan 28, 2026
traded Dec 12, 2025
+47dSEC FORM 4

Evidence

36
HA
Hasija AmitCFO & EVP of Corp. Development
MISTMilestone Pharmaceuticals Inc.
Grant or award
A—
100.0K sh
Dec 12, 2025Jan 28, 2026
traded Dec 12, 2025
+47dSEC FORM 4

Evidence

36
HA
Hasija AmitCFO & EVP of Corp. Development
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$24K
12.2K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC FORM 4

Evidence